The estimated Net Worth of Susan Desmond Hellmann is at least $2.21 Million dollars as of 15 May 2019. Susan Hellmann owns over 1,640 units of Pfizer stock worth over $974,450 and over the last 12 years he sold PFE stock worth over $1,237,467. In addition, he makes $0 as Director at Pfizer.
Susan has made over 30 trades of the Pfizer stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 1,640 units of PFE stock worth $48,642 on 15 May 2019.
The largest trade he's ever made was exercising 6,243 units of Pfizer stock on 15 May 2015 worth over $185,167. On average, Susan trades about 861 units every 35 days since 2012. As of 15 May 2019 he still owns at least 32,854 units of Pfizer stock.
You can see the complete history of Susan Hellmann stock trades at the bottom of the page.
Dr. Susan D. Desmond-Hellmann M.D. serves as Director of the Company. Dr. Desmond-Hellmann served as Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 until 2020, where she oversaw the creation of the Gates Medical Research Institute—the world’s first nonprofit biotech organization—as well as the launch of the Economic Mobility and Opportunity investment strategy in the U.S. She remains a Senior Advisor and Board member of the Gates Medical Research Institute. Prior to joining the Bill & Melinda Gates Foundation, she was the first female and ninth overall Chancellor of the University of California, San Francisco (UCSF) from 2009 until 2014, where she still serves as an adjunct professor. From 1995 through 2009, Dr. Desmond-Hellmann was employed at Genentech where she served as President of Product Development, from 2005-2009 overseeing pre-clinical and clinical development, business development and product portfolio management. Prior to joining Genentech, Dr. Desmond-Hellmann was Associate Director, Clinical Cancer Research at Bristol-Myers Squibb Pharmaceutical Research Institute. She served as a Director of Facebook Inc. from 2013 to 2019 and Procter & Gamble from 2010 to 2017. Dr. Desmond-Hellmann received a B.S. in Pre-Med and an M.D. from the University of Nevada and a M.P.H. from the University of California, Berkeley.
Susan Hellmann is 62, he's been the Director of Pfizer since 2020. There are 6 older and 22 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.
Susan's mailing address filed with the SEC is 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK, NY, 10001-2192.
Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read und James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer executives and other stock owners filed with the SEC include: